Subcutaneous · GLP-1 / GIP dual
Brenipatide
18 trials in this molecule. Source: ClinicalTrials.gov, as of November 5, 2026.
Trials
18
Ongoing
15
Recruiting
13
Completed
3
Sites
784
Countries
28
Endpoints
133
Composite endpoints
0
Distinct sites and countries across this molecule's trials. A site running several of its trials counts once, matching the map.
Where the program stands
Trials by phase
Phase 1
6
Phase 2
8
Phase 3
4
Trials by status
Recruiting
13
Active, not recruiting
2
Completed
3
Evidence coverage
What this asset has been measured on
Endpoints grouped into outcome categories, ranked by how often they are measured across this asset's trials.
Other (unclassified)
48
Safety / tolerability / PK
37
Weight & body composition
18
Patient-reported / QoL
12
Other clinical outcomes
9
Glycemic / diabetes
5
Cardiometabolic biomarkers
4
Top 20 metrics across this asset's endpoints
Programs for this asset
Every trial for this molecule, with the same search, filters, and sort as the Trials tab.
⌘K
18 of 18
Showing 1-18 of 18 trials